Clinical Trial Details


Research Study Summary



This study is evaluating 2 different treatment options for persistent atrial fibrillation. In this multi-center, pivotal clinical study, patients are randomized (2:1) to either a convergent procedure that includes both epicardial and endocardial atrial ablation versus standalone endocardial catheter ablation. The study will enroll and randomize one hundred and fifty three (153) patients from up to thirty (30) sites with twenty-seven (27) in the US and three (3) sites OUS.

To Learn more

CW ID: 218860
Date Last Changed: September 26, 2016

Clinical Trial Snapshot

Both Male and Female
18 to 80 Years
Overall Status
Lead Sponsor
5 Years
Facility Type


To be evaluated to participate in the study:

  • you have to be between the age of 18 to 80
  • have persistent atrial fibrillation (AF)
  • your current atrial fibrillation medications are not working
  • you have not undergone a previous ablation for your AF
  • you do not have an implanted ICD

More Info

Study participants will need to come for procedure follow-up visits at 7 days, 1 month, 3 months, 6 months and 12 months after undergoing the study procedure.

Study participants will be continued to be followed long term with an office visit at 18months and phone follow-up after that at year 2, 3, 4, and 5 post procedure.


DD Castillo
STAR Clinical Trials LLC
Located in:
San Antonio, TX 78229
Phone: 210-614-7827

View Map

Volunteer for this Trial

If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.